Stem Cell Clinic

Former Professional Football Player to Be a Spokesperson for Smartchoice Stem Cell Institute to Promote Adult Stem …

By Stem Cell Treatment

Jacksonville, FL (PRWEB) May 09, 2014

Tom McManus, former professional football player with the Jacksonville Jaguars is teaming up with SmartChoice Stem Cell Institute as a spokesperson. He and SmartChoice hope that the alliance will promote awareness of benefits and success of Adult Stem Cell procedures as non-surgical treatment for sports injuries, arthritis, joint and back pain.

McManus, who was a middle linebacker for the Jacksonville Jaguars, is a firm believer in the treatment. I think SmartChoice procedures are a great alternative to invasive surgery and want to let people know that this option exists in Jacksonville. Many athletes have been going to Germany for these types of treatments, and now they dont have to leave the United States.

SmartChoice Stem Cell Institute, SmartChoiceStemCell.com, located in Jacksonville, Florida, was founded by Dr. Hardesh Garg, M.D. Dr. G, as he is affectionately referred by his patients, has been practicing medicine for over 20 years but has focused his medical practice on Adult Stem Cells for almost five years. Regenerative Medicine and Adult Stem Cell treatments are the newest alternative to invasive orthopedic surgeries for joint problems and sports injuries. This is the future and we are honored to have Tom as our spokesperson as we move forward in this exciting medical field.

SmartChoice Adult Stem Cell Procedures use adult stem cells from a patients own body, harvested and injected in a same-day office procedure to regenerate and rejuvenate injured cells. These procedures are helpful not only for sports injuries, but also for arthritis and other joint and back problems.

Dr. Garg and McManus hope that this partnership will increase public awareness of SmartChoice Adult Stem Cell procedures. SmartChoice continues to help patients with a variety of sports injuries. McManus will use his NFL and public speaking experience to help Dr. Garg treat athletes with sports injuries, both amateur and professional, especially the ever-growing golf community in Florida and other states.

For more information about this topic, or to schedule an interview with Dr. Garg, please visit SmartChoiceStemCell.com or call Brooke Williams, Chief Clinical Consultant, at 904-997-6100 or email Brooke at consultant(at)smartchoicestemcell(dot)com

See original here:
Former Professional Football Player to Be a Spokesperson for Smartchoice Stem Cell Institute to Promote Adult Stem ...

New Vet-Stem Patent for Stem Cells Covers Sports Medicine Applications

By Stem Cell Medicine

Poway, California (PRWEB) May 08, 2014

Vet-Stem, Inc., announced that a major patent has been issued directly to Vet-Stem for New Zealand. This patent covers methods for extracting/preparing and using adipose tissue-derived stem cells for preventing or treating diseases in any mammal, including humans. This patent will provide coverage for the ongoing commercial and development programs at Vet-Stem and for its licensees in Australasia. This patent may be available for licensing for human applications to other companies interested in working in this field.

Of particular interest is the application to the rapidly evolving field of Regenerative Sports Medicine. This patent covers the preparation methods and use of adipose-derived stem cells in treating any type of disease, but specifically covers the use in injuries or diseases of the musculoskeletal system such as tendon tears, ligament injury and osteoarthritis.

This new patent issued to Vet-Stem adds to the many other patents in the Vet-Stem portfolio that cover methods of preparing and using regenerative cells from adipose. Vet-Stem has already had a similar patent issue in the EU and applications are pending in the US and other countries. In addition to these owned patents, Vet-Stem has exclusive worldwide rights to a portfolio of patents (over 50 issued and 70 pending patents) from Artecel, Inc. (including University of Pittsburgh patents) and the University of California, which further strengthens the companys intellectual property position in this rapidly developing field.

As the first company in the world to offer fat derived stem cell services for veterinary use, Vet-Stem has rapidly developed the market, providing treatments to over 10,000 horses, dogs, cat and exotic species. Intellectual property rights can be confusing in a rapidly developing market with evolving technology, said Bob Harman, DVM, MPVM, CEO of Vet-Stem. We needed to do everything possible to protect the market that we are creating in regenerative veterinary medicine and to ensure that the value of the company is optimized. The value of this technology has increased greatly since the founding of the company in 2002 as the business model, therapeutic activity of the cells, and ease of tissue collection have all been demonstrated.

About Vet-Stem, Inc. Vet-Stem, Inc. was formed in 2002 to bring regenerative medicine to the veterinary profession. The privately held company is working to develop therapies in veterinary medicine that apply regenerative technologies while utilizing the natural healing properties inherent in all animals. As the first company in the United States to provide an adipose-derived stem cell service to veterinarians for their patients, Vet-Stem, Inc. pioneered the use of regenerative stem cells in veterinary medicine. The company holds exclusive licenses to over 50 patents including world-wide veterinary rights for use of adipose derived stem cells. In the last decade over 10,000 animals have been treated using Vet-Stem, Inc.s services, and Vet-Stem is actively investigating stem cell therapy for immune-mediated and inflammatory disease, as well as organ disease and failure. For more on Vet-Stem, Inc. and Veterinary Regenerative Medicine visit http://www.vet-stem.com or call 858-748-2004.

Read the rest here:
New Vet-Stem Patent for Stem Cells Covers Sports Medicine Applications

Scientists Decode Epigenetic Mechanisms Distinguishing Stem Cell Function and Blood Cancer

By Stem Cell Medical Center

Contact Information

Available for logged-in reporters only

Newswise (Lebanon, NH, 5/8/14) Researchers at Dartmouths Norris Cotton Cancer Center have published results from a study Cell Reports that discovers a new mechanism that distinguishes normal blood stem cells from blood cancers.

These findings constitute a significant advance toward the goal of killing leukemia cells without harming the bodys normal blood stem cells which are often damaged by chemotherapy, said Patricia Ernst, PhD, co-director of the Cancer Mechanisms Program of the Norris Cotton Cancer Center and an associate professor in Genetics at Geisel School of Medicine.

The study focused on a pathway regulated by a gene called MLL1 (for Mixed Lineage Leukemia). Ernst served as principal investigator; Bibhu Mishra, PhD, as lead author.

When the MLL1 gene is damaged, it can cause leukemia, which is a cancer of the blood, often occurring in very young patients. Researchers found that the normal version of the gene controls many other genes in a manner that maintains the production of blood cells.

This control becomes chaotic when the gene is damaged or broken and that causes the normal blood cells to turn into leukemia, said Ernst.

The researchers showed that the normal gene acts with a partner gene called MOF that adds small acetyl chemical modification around the genes that it controls. The acetyl modification acts as a switch to turn genes on. When this function is disrupted, MLL1 cannot maintain normal blood stem cells.

The researchers also found that a gene called Sirtuin1 (more commonly known for controlling longevity) works against MLL1 to keep the proper amount of acetyl modifications on important stem cell genes. Blood cancers involving MLL1, in contrast, do not have this MOF-Sirtuin balance and place a different chemical modification on genes that result in leukemia.

Blood stem cells also represent an important therapy for patients whose own stem cells are destroyed by chemotherapy. This study also reveals a new way to treat blood stem cells from donors that would expand their numbers.

See original here:
Scientists Decode Epigenetic Mechanisms Distinguishing Stem Cell Function and Blood Cancer

Spurt of heart muscle cell division seen in mice well after birth: Implications for repair of congenital heart defects

By Uncategorized

The entire heart muscle in young children may hold untapped potential for regeneration, new research suggests.

For decades, scientists believed that after a child's first few days of life, cardiac muscle cells did not divide. Instead, the assumption was that the heart could only grow by having the muscle cells become larger.

Cracks were already appearing in that theory. But new findings in mice, scheduled for publication in Cell, provide a dramatic counterexample -- with implications for the treatment of congenital heart disorders in humans.

Researchers at Emory University School of Medicine have discovered that in young mice 15 days old, cardiac muscle cells undergo a precisely timed spurt of cell division lasting around a day. The total number of cardiac muscle cells increases by about 40 percent during this time, when the rest of the body is growing rapidly. [A 15-day-old mouse is roughly comparable to a child in kindergarten; puberty occurs at day 30-35 in mice.]

The burst of cell division is driven by a surge of thyroid hormone, the researchers found. This suggests that thyroid hormone could aid in the treatment of children with congenital heart defects. In fact, doctors have already tested thyroid hormone supplementation in this setting on a small scale.

The findings also have broader hints for researchers developing therapies for the heart. Activating the regenerative potential of the muscle cells themselves is a strategy that is an alternative to focusing on the heart's stem cells, says senior author Ahsan Husain, PhD, professor of medicine (cardiology) at Emory University School of Medicine.

"It's not as dramatic as in fish or amphibians, but we can show that in young mice, the entire heart is capable of regeneration, not just the stem cells," he says.

The Emory researchers collaborated with Robert Graham, MD, executive director of the Victor Change Cardiac Research Institute in Australia. Co-first authors of the paper are Nawazish Naqvi, PhD, assistant professor of medicine at Emory and Ming Li, PhD, at Victor Chang.

The researchers tested how much mice, at the age of day 15, can recover from the blockage of a coronary artery. Consistent with previous research, newborn (day 2) mice showed a high level of repair after such an injury, but at day 21, they did not. The day 15 mice recovered more than the day 21 mice, indicating that some repair is still possible at day 15.

The discovery came unexpectedly during the course of Naqvi and Husain's investigation of the role of the gene c-kit -- an important marker for stem cells -- in cardiac muscle growth. Adult mice with a disabled c-kit gene in the heart have more cardiac muscle cells. The researchers wanted to know: when does this difference appear?

Read more from the original source:
Spurt of heart muscle cell division seen in mice well after birth: Implications for repair of congenital heart defects

Dont be fooled by quacks and fake meds

By Uncategorized

Beware of fake medicines and advertisements touting the purported miracles that stem cell therapy can do. This was the warning aired by former health secretary Esperanza Cabral at the Kapihan sa Manila at the Diamond Hotel last Monday.

Contrary to what the ads claim, she said, stem cell therapy has not been scientifically proven to cure any disease or make anyone young again. It has been successful in a very few experiments, which is the reason quack doctors are taking advantage of it to make exaggerated claims that the therapy can cure the deadliest diseases known to man.

The Food and Drug Administration (FDA) very recently issued a similar warning against it.

Stem cell therapy is the process of injecting into patients young cells taken from humans or sheep. The theory is that the young cells will rejuvenate the old cells of the patients and make them young again and cure whatever diseases they have. Although experiments are being conducted, no such results have been achieved. But that does not prevent foreign quack doctors from coming here and making all those exaggerated claims. Sadly, they are aided by some Filipino doctors.

The reason is that in countries like the Philippines where the people are suckers for miracle cures, stem cell therapyand other miracle curesis like a gold mine.

Aging millionaires looking for the fountain of youth pay a lot of money to undergo stem cell therapy. Patients with terminal illnesses like cancer, in a desperate search for a cure, also fall victim to the sales talk and word-of-mouth yarns of so-and-so being cured by the therapy.

But they get neither younger nor cured. And the quack doctors run laughing with their patients money all the way to the bank.

A friend told me that he had gone abroad to have stem cell therapy. He said he felt better and stronger after the treatment. Look at me, dont I look younger? he said.

I looked at him. He didnt look a minute younger and in fact looked the same as when I last saw him, maybe even older.

My wife said I look younger, he said. It was his wife who had convinced him to have the stem cell therapy.

Read more from the original source:
Dont be fooled by quacks and fake meds

Stem Cell News | Stem Cell Treatment, Stem Cell Research …

By Stem Cell Treatment

In a study published today inF1000Research, Professor Kenneth Lee of the Chinese University of Hong Kong reveals the full experimental results of an attempt to replicate a controversial study published inNaturerecently that suggested that bathing somatic cells in acid can reprogram them to induced pluripotent stem cells (iPS cells). With systematically collected and fully available data, Lee and his colleagues report that carefully replicating the original acid-treatment method does not induce pluripotency in two types of mouse somatic cells, including those used in the original study.

Read the story

A subset of immune cells directly target colon cancers, rather than the immune system, giving the cells the aggressive properties of cancer stem cells.

Read the story

Adults suffering from diseases such as leukemia, lymphoma, and other blood-related disorders may benefit from life-saving treatment commonly used in pediatric patients. Researchers at the Icahn School of Medicine at Mount Sinai have identified a new technique that causes cord blood (CB) stems cells to generate in greater numbers making them more useful in adult transplantation.

Read the story

A new study inNaturechallenges research data that form the scientific basis of clinical trials in which heart attack patients are injected with stem cells to try and regenerate damaged heart tissue.

Read the story

By carefully controlling the levels of two proteins, researchers at theSalk Institutehave discovered how to keep mammary stem cellsthose that can form breast tissuealive and functioning in the lab. The new ability to propagate mammary stem cells is allowing them to study both breast development and the formation of breast cancers.

Read the story

See the rest here:
Stem Cell News | Stem Cell Treatment, Stem Cell Research ...

New Jersey Stem Cell Therapy | Stem Cell Treatments

By Stem Cell Treatment

New Jersey Stem Cell Therapy Worldstemcells.com is one of the leading stem cell therapy and treatment providers for residents of New Jersey and across the nation. Our cutting edge technology and compassionate staff truly set us apart from the competition. We are a US based company that understands your needs and concerns when looking for a stem cell treatment center. Our treatment center is located in Cancun, Mexico.

Conditions we treat include but not limited to:

Getting Started With Your Stem Cell Therapy and Treatments Here at World Stem Cells LLC we try to make the process of receiving stem cell transplants as easy as possible. We will help you figure out what your needs are and help you reach your goals as fast as possible. Follow the steps below on what to do.

Option 1 1.) Go to any page on our website and fill out the contact form. 2.) Fill in the required information and select the condition you would like to treat with stem cell therapy. 3.) Be sure to include any special information in the comments section. 4.) Click the submit button and we will contact you in a timely manner. 5.) Thats it, youre done!!!

REQUEST INFORMATION NOW!

Option 2

Call 800-234-1693 and speak with a representative regarding your stem cell therapy needs and requirements.

Read the original:
New Jersey Stem Cell Therapy | Stem Cell Treatments

Stem Cell Treatments – Stemgenex

By Stem Cell Treatment

For thousands of years physicians had 3 ways to treat patients; with surgery, drugs, and medical devices. These were considered the 3 pillars of medicine and society has benefited from major advances in these areas. Today, a 4th pillar of medicine, cellular based therapies or regenerative medicine is likely to dominate medical therapies in the future. Regenerative medicine uses the bodys own cells to treat diseases, repair damage, and restore structure and function.

We understand what it means to seek a good healthy quality of life and our doctors are focused on making positive differences in the lives of patients through innovative stem cell treatments and regenerative medicine treatments.

And it just so happens that you came equipped with stem cells, The Human Repair Kit and we know how to put it to work.

A 150-Year History of Autologous Treatments in Western Medicine There has not been a more powerful method in existence of healing the body than by using its own biology and chemistry. Skin grafting, which is the use of skin or a skin substitute to replace a non-healing wound, has been in existence since 800 BC. One of the earliest documented cases of attempted skin grafting occurred in India. The first successful autologous skin graft occurred in 1822.

(Information provided by Kate A. Lygoe , BSc, and Mark P. Lewis, PhD. Eastman Dental Institute, University College London)

Multiple Sclerosis Stem Cell Treatment

MS is a degenerative disease that involves the deterioration of nerve cells. Our Stem cell treatment and stem cell therapy works by resetting the patient's immune system through the use of stem cells. This Multiple Sclerosis stem cell therapy has helped patients who don't respond to typical drug treatment.

Learn More >>>

Alzheimer's Stem Cell Treatment

In a healthy brain, there are over 100 billion nerve cells connected to extensions. With the onset of Alzheimers disease, information transfer at the synapses (the connection between the nerve cells and extensions) starts to break down, and the number of synapses decreases significantly.

See the rest here:
Stem Cell Treatments - Stemgenex

$4 Million from Eli and Edythe Broad Foundation Will Support UCLA Research

By Stem Cell Treatment

Contact Information

Available for logged-in reporters only

Newswise Two new gifts from The Eli and Edythe Broad Foundation to UCLA totaling $4 million will fund research in stem cell science and digestive diseases and support the recruitment of key faculty at two renowned research centers.

The gifts bring to $30 million The Broad Foundation's total support of faculty recruitment and basic and translational research at the Eli and Edythe Broad Center of Regenerative Medicine and Stem Cell Research at UCLA and at the Center for Inflammatory Bowel Diseases at UCLA's Division of Digestive Diseases.

A $2 million gift to the Broad Stem Cell Research Center adds to The Broad Foundation's original 2007 gift of $20 million, which has supported faculty and research and launched the Innovation Award program, which furthers cutting-edge research at the center by giving UCLA stem cell scientists "seed funding" for their research projects. The new gift will enable the continuation of the award program, which has yielded a 10-to-1 return on investment with grantees securing additional funding from other agencies, including the National Institutes of Health and more than $200 million in total grants from the California Institute for Regenerative Medicine, the state's stem cell agency.

"The Broads' generous support has been essential to the development of new therapies that are currently in, or very near, clinical trials for treating blindness, sickle cell disease and cancer," said Dr. Owen Witte, director of the Broad Stem Cell Research Center. "The Broad Stem Cell Research Center's work, supported by critical philanthropic and other resources, is quickly being translated from basic scientific discoveries into new cellular therapies that will change the practice of medicine and offer future treatment options for diseases thought to be incurable, such as muscular dystrophy, autism and AIDS."

The $2 million gift to the Division of Digestive Diseases builds on nearly $6 million in previous commitments from The Broad Foundation since 2003.

The gifts have enabled the division to develop a comprehensive research and clinical enterprise focused on inflammatory bowel disease, one of only a few such centers in the world. Earning a multifold return for The Broad Foundation's initial investments, these grants have enabled investigators to secure $11 million in funding from pharmaceutical companies, the National Institutes of Health and nonprofit foundations.

In addition, The Broad Foundation's Broad Medical Research Program has provided more than $600,000 in grants to UCLA researchers over the past decade for the study of inflammatory bowel disease.

The new gift will support the Center for Inflammatory Bowel Diseases and research led by Dr. Charalabos "Harry" Pothoulakis, the center's director. Pothoulakis' team conducts research aimed at identifying the molecular mechanisms involved in the development of this group of chronic debilitating diseases, for which there is no cure.

See the article here:
$4 Million from Eli and Edythe Broad Foundation Will Support UCLA Research

Police say man used Facebook, Twitter to offer stem-cell treatment

By Stem Cell Treatment

A Lake Worth man is facing serious charges.

Jon Rubenstein is charged with one count of unlicensed practice of medicine, WPBF 25 News has learned.

MOBILE/TABLET USERS: Watch The Video

According to an arrest report, Palm Beach County Sheriff's detectives received a complaint from the Department of Health that Rubenstein is using social media to offer stem-cell therapy treatments for injured athletes.

Rubenstein has no professional medical licenses, but was the registered agent of Innovative Blood Technology Inc., and the Center for Natural Healing and Regenerative Medicine Inc., based in Margate.

An undercover agent contacted Rubenstein, who replied via email, saying he "has helped hundreds of people with arthritis live a pain-free life through stem-cell injection therapy."

A single injection is $300 and if a patient chooses to have the full, three-shot treatment, the charge is $750.

Rubenstein and the undercover agent scheduled to have the procedure take place at a home in Lake Worth. The suspect arrived wearing scrubs and carrying medical equipment when he met two undercover agents.

The Palm Beach County Diversion Task Force placed Rubenstein under arrest.

WPBF's attempts to contact him for comment were unsuccessful.

Read the original here:
Police say man used Facebook, Twitter to offer stem-cell treatment

→←